NCT01059643 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 103
- units
- Participants
- groups
- description
- LY2523355: Dose determined by participant body surface area: 5 milligrams/square meter(mg/m²) or 6 mg/m², administered intravenously as a one hour infusion on Days 1, 2 and 3 of a 21 day cycle for up to 2 cycles (4 cycles for prostate cancer participants). Additional cycles administered based on participant response assessment. Pegfilgrastim: 6 milligrams (mg), administered subcutaneously approximately 24 hours after third dose of LY2523355 on Day 4 of each 21-day cycle, for up to 2 cycles of LY2523355 administration (4 cycles for prostate cancer participants). Additional cycles of LY2523355 administered based on participant response assessment.
- id
- BG000
- title
- LY2523355
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 10.30
- value
- 62.3
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 33
- title
- Female
- measurements
- group Id
- BG000
- value
- 70
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 2
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 101
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 2
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 8
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 93
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 0
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 103
- title
- United States
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Region of Enrollment
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 17
- title
- Colorectal Cancer
- categories
- measurements
- group Id
- BG000
- value
- 13
- title
- Gastroesophageal Cancer
- categories
- measurements
- group Id
- BG000
- value
- 29
- title
- Non-Small Cell Lung Cancer
- categories
- measurements
- group Id
- BG000
- value
- 13
- title
- Ovarian Cancer
- categories
- measurements
- group Id
- BG000
- value
- 18
- title
- Prostate Cancer
- categories
- measurements
- group Id
- BG000
- value
- 13
- title
- Squamous Cell Carcinoma of the Head and Neck
- param Type
- NUMBER
- title
- Tumor Type
- unit Of Measure
- participants
- population Description
- All enrolled participants.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 103
- units
- Participants
- groups
- description
- LY2523355: Dose determined by participant body surface area: 5 milligrams/square meter(mg/m²) or 6 mg/m², administered intravenously as a one hour infusion on Days 1, 2 and 3 of a 21 day cycle for up to 2 cycles (4 cycles for prostate cancer participants). Additional cycles administered based on participant response assessment. Pegfilgrastim: 6 milligrams (mg), administered subcutaneously approximately 24 hours after third dose of LY2523355 on Day 4 of each 21-day cycle, for up to 2 cycles of LY2523355 administration (4 cycles for prostate cancer participants). Additional cycles of LY2523355 administered based on participant response assessment.
- id
- BG000
- title
- LY2523355
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 10.30
- value
- 62.3
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 33
- title
- Female
- measurements
- group Id
- BG000
- value
- 70
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 2
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 101
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 2
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 8
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 93
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 0
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 103
- title
- United States
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Region of Enrollment
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 17
- title
- Colorectal Cancer
- categories
- measurements
- group Id
- BG000
- value
- 13
- title
- Gastroesophageal Cancer
- categories
- measurements
- group Id
- BG000
- value
- 29
- title
- Non-Small Cell Lung Cancer
- categories
- measurements
- group Id
- BG000
- value
- 13
- title
- Ovarian Cancer
- categories
- measurements
- group Id
- BG000
- value
- 18
- title
- Prostate Cancer
- categories
- measurements
- group Id
- BG000
- value
- 13
- title
- Squamous Cell Carcinoma of the Head and Neck
- param Type
- NUMBER
- title
- Tumor Type
- unit Of Measure
- participants
- population Description
- All enrolled participants.
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle